Life science companies, from emerging to evolved, therapeutics to diagnostics, solo or partnered, are constantly fundraising. Each enterprise must make strategic choices along the way about its desired funding composition and timing, target investor mix, and how they build value. In this Expert Class financing options and successful strategies for young Life Sciences & MedTech companies are being discussed. The focus is on financing options for biotech and MedTech companies until series A financing round. The topics will be addressed from different perspectives and experts like dilutive non-dilutive financing, term sheets, subsidies and vouchers, tax incentives and convertible loans will be discussed. Also the involvement of experienced CEO’s and CFO’s in your Management team will be addressed.
Next to the presentations all topics will also be discussed during a panel discussion where participants also could bring in their cases. During the programme there is sufficient time for networking.
The expert class program is set up in an interactive way such that the participants have also the possibility to bring their own questions and discuss issues they encounter in their own (start-up) company and/or business case. The experts will give you feedback on your questions.
We ask all participants to send their casus not later than May 24th 2022 to firstname.lastname@example.org.
13.00 hrs. Welcome
13.30 hrs. Start Expert Class by Chrétien Herben (moderator)
Pitch participants (2 min. per participant):
- Company presentation and/or business case
- Share questions and/or issues on the topic
14.00 hrs. Patricia Celie PhD, Principal Consultant, Catalyze
Catalyze supports researchers and companies to secure funding for ambitious R&D projects, from early stage, fundamental research up until late-stage development. The expert of Catalyze will give an overview of the (inter)national subsidy landscape that are available for young Life sciences companies to get non-dilutive funding.
15.00 hrs. Marc van Moorsel (COO), TargED Biopharmaceuticals
TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. Only 4 years about founding the company TargED Biopharmaceuticals raised 39 million in a series A investment round. Marc van Moorsel and Kristof Vercruysse will share their insights and used strategy towards this successful investment round.
15.45 hrs. Mercedes Tuin, Senior investment Manager Lifesciences & MedTech, BOM
The Brabant Development Agency (BOM) ensures that startups receive the right support and funding to get off to a flying start and grow into scaleups, and that companies that aspire to go global can actually do so. Mercedes Tuin will share how and under which terms a regional development agency invests in young life sciences companies throughout the stages of its life-cycle.
16.30 hrs. Discuss questions and issues from participants with the experts
17.15 hrs. Drinks, bites and networking!
18.00 hrs. End of Expert Class
LifeSciences@Work Expert Classes are a series of targeted workshops organised in close collaboration with industry and academic experts
- The small-scale and personalised Expert Classes welcome Venture Challenge Alumni, Value Centre Alumni and NWO Take off Alumni.
- New early startups not (yet) part of our LS@W community but interested to join are also very welcome, provided there is a match with the LS@W community profile.
- Participation is free-of-charge for startup teams.
Registration is needed to attend!
Please send an e-mail to email@example.com to receive your confirmation and additional final information.